Physician profile
Jonathan Weiser
NPI 1104963958
$1,871.97
in general payments reported to CMS, 2019-2025
17 companies · $147 in 2025
The $147 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $545 · 2020: $86.56 · 2021: $604 · 2022: $161 · 2023: $129 · 2024: $199 · 2025: $147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $475.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $474.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sientra, INC. | $811.47 | 2019-2022 | |
| Biom'Up France Sas | $264.92 | 2021 | |
| Abbvie INC. | $240.73 | 2024-2025 | |
| Mentor Worldwide LLC | $121.38 | 2020-2024 | Mentor Memorygel Resterilizable Gel Sizer |
| Tela Bio, INC. | $69.70 | 2020-2021 | |
| Hologic Sales and Service, LLC | $62.07 | 2023-2025 | Aptima, Affirm Prone Biopsy System, Thinprep 2000 Processor |
| Dilon Technologies, INC. | $52.67 | 2023 | Hemoblast Bellows |
| Stryker Corporation | $42.83 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $32.20 | 2023 | Seglentis |
| Pfizer INC. | $31.51 | 2019 | |
| Sanara Medtech INC. | $28.04 | 2021 | |
| Becton, Dickinson and Company | $27.96 | 2023-2024 | Bd Onclarity |
| Merz North America, INC. | $22.46 | 2025 | |
| Acelrx Pharmaceuticals, INC. | $21.54 | 2021 | |
| Baudax Bio INC. | $19.24 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $17.11 | 2023 | Prevena Restor Bellaform, V.A.C. Veraflo Cleanse Choice, Prevena |
| Amniox Medical, INC. | $6.14 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Weiser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.